Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:
“Beyond one biomarker:
CheckMate 9ER dives deep into the tumor microenvironment.
ML-integrated biomarkers > single markersTumor + blood features → better prediction of NIVO+CABO benefit!
It’s patterns, not parts.”
More posts featuring ASCO25.
